HELWAN UNIVERSITY

ACTIVE

Ain Helwan, Helwan, Cairo, Egyptwww.helwan.edu.egPrivate5,001–10,000 employeesEstablished: 1975-01-01

Clinical Trials

11 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1975

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

42.0%

Phase 3

13.0%

Phase 4

13.0%

Phase 2

8.7%

Trial Status Distribution

Active, not recruiting

4.3%

Completed

71.0%

Enrolling By Invitation

1.4%

Not yet recruiting

10.1%

Recruiting

13.0%

Clinical Trials

Trials sponsored by this organization (69)

Continuous Infusion Versus Intermittent IV Bolus of Cefazolin: Prevention of Surgical Site Infection During CABG Surgeries in Egyptian Patients.

Phase 4

Not yet recruiting

interventional

Jul 2026100 participants

Continuous Infusion Versus Intermittent IV Bolus of Cefazolin: Prevention of Surgical Site Infection During Orthopedic Surgeries in Egyptian Patients.

Phase 4

Not yet recruiting

interventional

Jul 2026100 participants

Colistin Nephrotoxicity and Role of Alpha Lipoic Acid

Phase 3

Not yet recruiting

interventional

Jun 202688 participants

Model-Informed Precision Dosing of Tacrolimus in Pediatric Kidney Transplantation

Not yet recruiting

observational

Jun 2026130 participants

Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation

Phase 3

Recruiting

interventional

May 202670 participants

Using Retrograde Intrarenal Surgery for Managing Staghorn Renal Stones.

Not Applicable

Recruiting

interventional

Jan 2026100 participants

Innovative Insulin Injection Sites Map to Minimize Lipohypertrophy Risk

Not Applicable

Completed

interventional

Jun 2025170 participants

A Direct Head-to-head Comparison of Ustekinumab With Infliximab for the Treatment of Ulcerative Colitis

Active, not recruiting

observational

May 2025100 participants

Page 1 of 9

Approvals

No approval data available

News

No news articles found

Back to Organizations